McKesson publishes white paper integrating behavioral coaching to boost adherence
SAN FRANCISCO– In conjunction with its sponsorship of the CBI Conference, McKesson on Tuesday announced the launch of a new whitepaper discussing how brands can effectively combat nonadherence by integrating behavioral coaching into comprehensive patient support programs.
“The convergence of drug prices and patients’ rising financial obligations increases the likelihood of medication nonadherence by patients. Fortunately, there are effective tools to mitigate the risk of financially motivated primary fill abandonment,” stated Reagan Tully, VP product strategy for McKesson Specialty Health.
“However, it’s important to realize that most nonadherence is the result of behavioral barriers, such as low self-efficacy, lack of engagement or medication concerns, and addressing these is critical to improving compliance to a course of therapy," she said. "Leveraging behavioral coaching across communication channels, hub services and pharmacy channels allows brands to reach patients where they are within their treatment journey to build an integrated patient experience, drive positive health outcomes and increase medication adherence.”
At the conference, Tully led a session titled “Formulary Breakthroughs — Moving Beyond Co-Pay Programs to Encourage Collaboration and Improve Patient Outcomes.” The session addressed key payer challenges within the market impacting patient out of pocket costs. The discussion focused on new methods for manufacturers to collaborate with payers and explore innovative, implementable solutions to ease patient cost burden, ultimately to drive patient adherence and outcomes.
Alere Reader, a point-of-care influenza diagnostic, gains 510(k) clearance
WALTHAM, Mass. – Alere on Tuesday announced that its Alere Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings, has received 510(k) marketing clearance from the U.S. Food and Drug Administration.
“The Alere BinaxNOW Influenza A & B Card 2 test with the Alere Reader, improves what is already a leading rapid testing solution for influenza diagnosis in two key ways – by eliminating operator subjectivity and by connecting test results with information management systems,” stated Avi Pelossof, Alere Global president of infectious disease. “The Alere Reader platform, paired with Alere’s market-leading lateral flow portfolio, will ensure that over time this novel technology will be accessible for use with a wide variety of diseases and conditions across numerous clinical settings.”
With the Alere Reader, physicians, lab technicians and other healthcare personnel insert test cards into the platform, which detects, identifies and analyzes the completed lateral flow assay. Results are displayed on an intuitive touch screen, can immediately be linked to patient electronic medical records and back-end information systems, or can be printed. Further, the Alere Reader provides the user additional confidence in the results with an automated function that ensures quality controls have been tested.
This announcement represents the introduction into the U.S. market of the Alere Reader, a diagnostic platform with objective result interpretation and connectivity capabilities. This follows a successful release of the Alere Reader into Europe and select Asian markets.
Diplomat appoints new CFO
FLINT, Mich. — Diplomat Pharmacy on Tuesday named Atul Kavthekar as its CFO and treasurer, effective May 1. Kavthekar will head up Diplomat’s financial operations and investor relations, as well as managing the company’s liquidity, balance sheet risk and capital market transactions, reporting directly to CEO and chairman Phil Hagerman.
“I couldn’t be more excited to welcome Atul to the Diplomat team,” Hagerman said. “He is highly qualified to lead our finance and accounting teams. In addition to his previous CFO experience, Atul has a deep background in financial management, operational improvement, and company leadership, as well as strategic corporate and business development.”
Kavthekar has more than 20 years of experience in finance, most recently serving as CFO at e-retailer LivingSocial from June 2015 to December 2016, where he was responsible for the company’s overall financial and operational business improvement. He also has worked at Walgreens and Sears Holdings’ health and wellness division (which includes Kmart pharmacy) in executive roles. He has experience as an investment banker, as well as in mergers and acquisitions.
“I have long been an admirer of the company and look forward to adding to the company’s strong reputation as a leader in the specialty pharmacy industry,” Mr. Kavthekar said. “As the leading independent specialty pharmacy, Diplomat has tremendous opportunity, and I look forward to contributing to its success.